Answers are grounded in this paper and cite their sources.
This research assesses nemolizumab effectiveness and safety for treatment of severe pruritus in patients with cutaneous T-cell lymphoma.
No takes yet. Share an insight, caveat, or question.
Nayudu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: